With the analysis among 55,784 patents, we discovered top 478 key players by total patent application. Bristol Myers Squibb Co., AstraZeneca Pharmaceutical Co., Ltd., Novartis AG are dominant in this area. They take 6.52% of the total patent filing.
New York, United States
Patent: 1,487
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 1,096
Basel-Stadt, Switzerland
Patent: 1,056
F. Hoffmann-La Roche Ltd.
Connecticut, United States
Patent: 1,006
New York, United States
Patent: 940
Ono Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 825
New Jersey, United States
Patent: 771
Illinois, United States
Patent: 769
Enanta Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 735
With the analysis among 1,284 patents, we discovered top 103 start-ups by total patent application. Shenzhen Tajirui Biomedical Co. Ltd., Inflazome Ltd., GenFleet Therapeutics (Shanghai) Co., Ltd. are active in this area.
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 273
DUBLIN, Ireland
Patent: 161
GenFleet Therapeutics (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 59
Telangana, India
Patent: 48
Concentric Analgesics, Inc.
California, United States
Patent: 44
Institut National de la Santé et de la Recherche Médicale
Sumitomo Dainippon Pharma Oncology, Inc.
Shanghai KeChow Pharmaceuticals Co., Ltd.
Shanghai Shi, China
Patent: 27
Utah, United States
Patent: 27
Essex, United Kingdom
Patent: 23
With the analysis among related 11,511 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Shenzhen Tajirui Biomedical Co. Ltd., Inflazome Ltd., Novartis AG take 4.18% of patent filing during this period.
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 166
DUBLIN, Ireland
Patent: 161
Basel-Stadt, Switzerland
Patent: 154
Sunshine Lake Pharma Co. Ltd.
Guangdong Sheng, China
Patent: 132
New York, United States
Patent: 123
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 122
Shenyang Pharmaceutical University
Liaoning Sheng, China
Patent: 119
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 112
Enanta Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 109
Hovedstaden, Denmark
Patent: 107
With the analysis among related 11,511 patents in last 5 years, we discover 191 new entrants. Inflazome Ltd., Wuhan Renfu Innovative Drug Research and Development Center Co., Ltd., GenFleet Therapeutics (Shanghai) Co., Ltd. are the most active new entrants in this area.
DUBLIN, Ireland
Patent: 161
Wuhan Renfu Innovative Drug Research and Development Center Co., Ltd.
Hubei Sheng, China
Patent: 88
GenFleet Therapeutics (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 59
Zhejiang Jinfang Pharmaceutical Co Ltd
Zhejiang Sheng, China
Patent: 52
Beijing Tide Pharmaceutical Co., Ltd.
Beijing Shi, China
Patent: 50
Hinova Pharmaceuticals, Inc.
Sichuan Sheng, China
Patent: 42
Chengdu Baiyu Pharmaceutical Co., Ltd.
Sichuan Sheng, China
Patent: 40
Delaware, United States
Patent: 38
Connecticut, United States
Patent: 34
TaiGen Biotechnology Co., Ltd.
Taiwan Province, China
Patent: 33
With the analysis among 7,878 patents, we discovered top 271 universities and scientific research institutions by total patent application. Emory University, Shanghai Institute of Materia Medica Chinese Academy of Sciences, Shenyang Pharmaceutical University are dominant in this area. They take 11.40% of the total patent filing.
Georgia, United States
Patent: 352
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 189
Shenyang Pharmaceutical University
Liaoning Sheng, China
Patent: 181
The Johns Hopkins University
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 138
The European Molecular Biology Laboratory
Baden-Württemberg, Germany
Patent: 128
The Scripps Research Institute
California, United States
Patent: 94
Victoria, Australia
Patent: 91
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 79
North Carolina, United States
Patent: 73